(VIANEWS) – Titan Machinery (TITN), Kiniksa Pharmaceuticals, Ltd. (KNSA), Realty Income Corporation (O) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Titan Machinery (TITN)
24.4% sales growth and 21.97% return on equity
Titan Machinery Inc. owns and operates a network of full-service agricultural and construction equipment stores in the United States and Europe. It operates through three segments: Agriculture, Construction, and International. The company sells new and used equipment, including agricultural and construction equipment manufactured under the CNH Industrial family of brands, as well as equipment from various other manufacturers. Its agricultural equipment includes machinery and attachments for use in the production of food, fiber, feed grain, and renewable energy; and home and garden applications, as well as maintenance of commercial, residential, and government properties. The company's construction equipment comprises heavy construction machinery, light industrial machinery for commercial and residential construction, road and highway construction machinery, and energy and forestry operations equipment. It also sells maintenance and replacement parts. In addition, the company offers repair and maintenance services that include warranty repairs, off-site and on-site repair services, scheduling off-season maintenance services, and notifying customers of periodic service requirements; and training programs to customers. Further, it rents equipment; and provides ancillary equipment support services, such as equipment transportation, global positioning system signal subscriptions and other precision farming products, farm data management products, and CNH Industrial finance and insurance products. The company operates in Colorado, Iowa, Minnesota, Montana, Nebraska, North Dakota, South Dakota, Wisconsin, and Wyoming, the United States; and Bulgaria, Germany, Romania, Serbia, and Ukraine, Europe. Titan Machinery Inc. was founded in 1980 and is headquartered in West Fargo, North Dakota.
Earnings Per Share
As for profitability, Titan Machinery has a trailing twelve months EPS of $5.13.
PE Ratio
Titan Machinery has a trailing twelve months price to earnings ratio of 5.18. Meaning, the purchaser of the share is investing $5.18 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.97%.
Moving Average
Titan Machinery’s value is below its 50-day moving average of $29.18 and way under its 200-day moving average of $33.82.
Sales Growth
Titan Machinery’s sales growth for the next quarter is 24.4%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 16.4% and positive 16% for the next.
Volume
Today’s last reported volume for Titan Machinery is 153052 which is 14.61% below its average volume of 179252.
Previous days news about Titan Machinery(TITN)
- Zacks.com featured highlights include titan machinery, pvh, unum, AAR and valero energy. According to Zacks on Tuesday, 10 October, "Chicago, IL - October 10, 2023 - Stocks in this week’s article are Titan Machinery Inc. (TITN Quick QuoteTITN – Free Report) , PVH Corp. (PVH Quick QuotePVH – Free Report) , Unum Group (UNM Quick QuoteUNM – Free Report) , AAR Corp. (AIR Quick QuoteAIR – Free Report) and Valero Energy Corp. (VLO Quick QuoteVLO – Free Report) ."
2. Kiniksa Pharmaceuticals, Ltd. (KNSA)
15.5% sales growth and 81.84% return on equity
Kiniksa Pharmaceuticals, Ltd., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need worldwide. Its product candidates include Rilonacept, which is in Phase III clinical trials for the treatment of recurrent pericarditis, an inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody that is in Phase II clinical trials for the treatment of giant cell arteritis; and Vixarelimab, a monoclonal antibody, which is in Phase 2a clinical trial for the treatment of prurigo nodularis, a chronic inflammatory skin condition. The company's preclinical product candidates comprise KPL-404, a monoclonal antibody inhibitor of the CD40/CD40L interaction, a central control node of T-cell-dependent, and B-cell-mediated humoral adaptive immunity. The company has a clinical collaboration with Kite Pharma, Inc. to evaluate the combination of Yescarta and Mavrilimumab in patients with relapsed or refractory Large B-Cell lymphoma. Kiniksa Pharmaceuticals, Ltd. was founded in 2015 and is based in Hamilton, Bermuda.
Earnings Per Share
As for profitability, Kiniksa Pharmaceuticals, Ltd. has a trailing twelve months EPS of $3.12.
PE Ratio
Kiniksa Pharmaceuticals, Ltd. has a trailing twelve months price to earnings ratio of 5.1. Meaning, the purchaser of the share is investing $5.1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 81.84%.
Sales Growth
Kiniksa Pharmaceuticals, Ltd.’s sales growth is negative 13.4% for the ongoing quarter and 15.5% for the next.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 105.3% and a negative 366.7%, respectively.
Moving Average
Kiniksa Pharmaceuticals, Ltd.’s worth is under its 50-day moving average of $17.44 and above its 200-day moving average of $14.55.
Yearly Top and Bottom Value
Kiniksa Pharmaceuticals, Ltd.’s stock is valued at $15.92 at 20:22 EST, way under its 52-week high of $20.65 and way above its 52-week low of $10.29.
3. Realty Income Corporation (O)
15.2% sales growth and 3.02% return on equity
Realty Income, The Monthly Dividend Company, is an S&P 500 company and member of the S&P 500 Dividend Aristocrats index. We invest in people and places to deliver dependable monthly dividends that increase over time. The company is structured as a real estate investment trust ("REIT"), and its monthly dividends are supported by the cash flow from over 13,100 real estate properties primarily owned under long-term net lease agreements with commercial clients. To date, the company has declared 637 consecutive monthly dividends on its shares of common stock throughout its 54-year operating history and increased the dividend 121 times since Realty Income's public listing in 1994 (NYSE: O).
Earnings Per Share
As for profitability, Realty Income Corporation has a trailing twelve months EPS of $1.34.
PE Ratio
Realty Income Corporation has a trailing twelve months price to earnings ratio of 37.54. Meaning, the purchaser of the share is investing $37.54 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.02%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Realty Income Corporation’s EBITDA is 69.37.
Moving Average
Realty Income Corporation’s worth is under its 50-day moving average of $55.32 and way under its 200-day moving average of $60.91.
Volume
Today’s last reported volume for Realty Income Corporation is 1848480 which is 65.73% below its average volume of 5395310.
Yearly Top and Bottom Value
Realty Income Corporation’s stock is valued at $50.31 at 20:22 EST, way below its 52-week high of $68.85 and above its 52-week low of $48.42.
4. Waste Connections (WCN)
9.8% sales growth and 11.7% return on equity
Waste Connections, Inc. provides non-hazardous waste collection, transfer, disposal, and resource recovery services in the United States and Canada. It offers collection services to residential, commercial, municipal, industrial, and exploration and production (E&P) customers; landfill disposal services; and recycling services for various recyclable materials, including compost, cardboard, mixed paper, plastic containers, glass bottles, and ferrous and aluminum metals. The company also owns and operates transfer stations that receive compact and/or load waste to be transported to landfills or treatment facilities through truck, rail, or barge; and intermodal services for the rail haul movement of cargo and solid waste containers in the Pacific Northwest through a network of intermodal facilities. In addition, it provides E&P waste treatment, recovery, and disposal services for waste resulting from oil and natural gas exploration and production activity, such as drilling fluids, drill cuttings, completion fluids, and flowback water; production wastes and produced water during a well's operating life; contaminated soils that require treatment during site reclamation; and substances, which require clean-up after a spill, reserve pit clean-up, or pipeline rupture. Further, the company offers leasing services to its customers. Waste Connections, Inc. was founded in 1997 and is based in Woodbridge, Canada.
Earnings Per Share
As for profitability, Waste Connections has a trailing twelve months EPS of $3.24.
PE Ratio
Waste Connections has a trailing twelve months price to earnings ratio of 42.25. Meaning, the purchaser of the share is investing $42.25 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.7%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.3%, now sitting on 7.67B for the twelve trailing months.
Sales Growth
Waste Connections’s sales growth is 10% for the current quarter and 9.8% for the next.
Moving Average
Waste Connections’s worth is under its 50-day moving average of $138.79 and under its 200-day moving average of $137.25.
Volume
Today’s last reported volume for Waste Connections is 286341 which is 64.83% below its average volume of 814342.
5. The Joint Corp. (JYNT)
6.1% sales growth and 10.61% return on equity
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics in the United States. The company operates through two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and the sale of regional developer rights. As of January 27, 2021, the company operated approximately 550 locations in the United States. The company was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Earnings Per Share
As for profitability, The Joint Corp. has a trailing twelve months EPS of $0.21.
PE Ratio
The Joint Corp. has a trailing twelve months price to earnings ratio of 43.43. Meaning, the purchaser of the share is investing $43.43 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.61%.
Moving Average
The Joint Corp.’s worth is way below its 50-day moving average of $10.93 and way below its 200-day moving average of $14.28.
Volume
Today’s last reported volume for The Joint Corp. is 98720 which is 35.5% below its average volume of 153070.
Earnings Before Interest, Taxes, Depreciation, and Amortization
The Joint Corp.’s EBITDA is 1.33.
6. The Hershey Company (HSY)
5.4% sales growth and 54.35% return on equity
The Hershey Company, together with its subsidiaries, engages in the manufacture and sale of confectionery products and pantry items in the United States and internationally. The company operates through three segments: North America Confectionery, North America Salty Snacks, and International. It offers chocolate and non-chocolate confectionery products; gum and mint refreshment products, including mints, chewing gums, and bubble gums; pantry items, such as baking ingredients, toppings, beverages, and sundae syrups; and snack items comprising spreads, bars, snack bites, mixes, popcorn, and pretzels. The company provides its products primarily under the Hershey's, Reese's, Kisses, Jolly Rancher, Almond Joy, Brookside, barkTHINS, Cadbury, Good & Plenty, Heath, Kit Kat, Payday, Rolo, Twizzlers, Whoppers, York, Ice Breakers, Breath Savers, Bubble Yum, Lily's, SkinnyPop, Pirates Booty, Paqui, Dot's Homestyle Pretzels, and ONE Bar brands, as well as under the Pelon Pelo Rico, IO-IO, and Sofit brands. It markets and sells its products to wholesale distributors, chain grocery stores, mass merchandisers, chain drug stores, vending companies, wholesale clubs, convenience stores, dollar stores, concessionaires, and department stores. The company was founded in 1894 and is headquartered in Hershey, Pennsylvania.
Earnings Per Share
As for profitability, The Hershey Company has a trailing twelve months EPS of $8.69.
PE Ratio
The Hershey Company has a trailing twelve months price to earnings ratio of 21.54. Meaning, the purchaser of the share is investing $21.54 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 54.35%.
Moving Average
The Hershey Company’s value is way below its 50-day moving average of $214.39 and way below its 200-day moving average of $238.95.
